General Inquiries
hr@neoteryx.com
Americas
sales@neoteryx.com
Europe
europe@neoteryx.com
Rest of World
info@neoteryx.com
US | 8:00 am - 5:00 pm PST
tel: +1 (310) 787-8747
EUROPE / UK | 08:30 - 05:30 GMT
tel: +44 1908 568844
Fax Number: (310) 787-8770
421 Amapola Ave, Torrance, CA 90501
Neoteryx is headquartered in the US, with international offices in the UK and Netherlands.
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.